Diabetes, Gestational
Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETICS). Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA.
Subtype terms (1)
More specific conditions that are subtypes of Diabetes, Gestational in the MeSH hierarchy.
- Fetal Macrosomia
4 drugs approved
Drugs by status
Approved for this indication (3)
Phase 4 trials (15)
Phase 3 trials (3)
Phase 2 trials (3)
Phase 1 trials (4)
Organizations
Organization Involved with Phase 4 Indications (30)
- Novo Nordisk
- United States Army
- University Hospital, Gentofte, Copenhagen
- University of Manitoba
- University of Pittsburgh
- AGUNCO Obstetrics and Gynecology Centre
- Cairo University
- University of London
- Federal University of Rio Grande do Sul
- Georgetown University
- Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes
- Medical College of Wisconsin
- Medical University of Lodz
- University of Pisa
- University of Tampere
- William Sansum Diabetes Center
- Statens Serum Institut
- University of Copenhagen
- University of Naples Frederico II
- University of Turku
- Sansum Diabetes Research Institute
- Jiao Tong University
- Emek Medical Center
- Government of Mexico
- HCPA-UFRGS
- Magna Graecia University
- University of Texas at Houston
- University Parthenope of Naples
- Children's Hospital Research Institute of Manitoba
- The University of Texas, Dallas
Organization Involved with Phase 3 Indications (33)
- Boehringer Ingelheim
- Maastricht University
- Ain Shams University
- Bethesda Diabetes Research Center
- Brown University
- Dow University of Health Sciences
- Hospital Civil Juan I. Menchaca
- Minia University
- Services Institute of Medical Sciences, Pakistan
- University of Eastern Finland
- University of Edinburgh
- University of Groningen
- University of Oslo
- University of Oulu
- University of Toronto
- Utrecht University
- Woman's Hospital, Louisiana
- Royal College of Surgeons, Ireland
- University of Modena and Reggio Emilia
- Icahn School of Medicine at Mount Sinai
- Technion University
- Antiguo Hospital Civil de Guadalajara Fray Antonio Alcalde
- University of Paris
- Ben Gurion University
- University of Sherbrooke
- Canadian Institutes of Health Research (CIHR)
- Health Research Board, Ireland
- Government of Scotland
- University of Helsinki
- Government of Spain
- +3 more
Organization Involved with Phase 2 Indications (10)
Organization Involved with Phase 1 Indications (8)
Organization Involved with Other Experimental Indications (28)
- Swiss Federal Institute of Technology
- United States Air Force
- Dr. Sami Ulus Children's Hospital
- Aarhus University
- Allegiance Health
- D'Annunzio University of Chieti–Pescara
- Geisinger Clinic
- Instituto Mexicano del Seguro Social
- Maimonides Medical Center
- Regional Obstetrical Consultants
- St. Luke's-Roosevelt Hospital Center
- Texas Tech University
- University of Messina
- University of New Mexico
- K. Marcinkowski University of Medical Sciences
- Penang Medical College
- Poznan University
- University of California, Davis
- University of California, Irvine
- University of California, Los Angeles
- Zhejiang University
- Long Beach Memorial Medical Center
- Sun Yat-Sen University
- University of Tennessee, Chattanooga
- National Natural Science Foundation of China
- Chinese Academy of Medical Sciences
- Imperial College London
- University of Nevada, Las Vegas